E Therapeutics (ETX)

 

ETX Share PerformanceMore

52 week high14.9000 06/06/16
52 week low7.0000 22/12/16
52 week change -6.1250 (-42.61%)
4 week volume1,388,611 01/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

e-Therapeutics operating losses rise

e-Therapeutics' operating losses rose to 16.3m in the year to the end of January - up from 11.55m. The figure included impair...

Final Results

Announcement of full year/4th quarter financial results

Notification of Full Year Results Date

Notification of the date financial results will be published

New CEO Commences at e-Therapeutics

Miscellaneous medium priority announcements

Holding(s) in Company

Notification of major interests in shares

Holding(s) in Company

Notification of major interests in shares

Directorate Change

Notification of any change to a company’s board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director

Holding(s) in Company

Notification of major interests in shares

Fundamental DataMore

EPS-4.91
Dividend yield0 %

Equity Research (ETX)

edison investment research
e-Therapeutics plc
16/01/2017
e-Therapeutics (ETX) has appointed a new CEO, Dr Raymond Barlow, who will join the company by 1 May 2017. He brings significant R&D and business development experience, which will be invaluable...
edison investment research
e-Therapeutics plc.
20/09/2016
e-Therapeutics (ETX) is focused on driving value in its discovery platform. Costs will be reduced as the 17 product candidates in discovery as of July 2016 have been cut to a core five. Cash of £19....
edison investment research
e-Therapeutics plc.
19/05/2016
e-Therapeutics’ strategy has evolved, shifting from investment into its proprietary discovery platform to commercialisation of its 12 preclinical assets and the platform itself. Out-licensing and...

Latest discussion posts More

  • Q1 2017 blog update - ETX

    Q1 2017 blog weekly ETX chart update - notes under each chart: http://bonker99.com/Blogs
    10-Feb-2017
    Bonker
  • ETX chart

    http://bonker99.com/charts
    6-Feb-2017
    Bonker
  • Results

    RNS available at company's website. although seems to be missing in III ...
    22-Mar-2016
    nk1999

Users' HoldingsMore

Users who hold E Therapeutics also hold..
LLOYDS GRP.26%
ROCKHOPPER26%
RENEURON26%
RANGE RES.23%
PREMIER OIL19%

Codes & Symbols

ISINGB00B2823H99
SymbolsETX, LSE:ETX, ETX.L, ETX:LN, LON:ETX, XLON:ETX